<p>Amedisys, Inc.（纳斯达克代码：AMED - 获取免费报告）在周四的交易量有所上升。中午交易时段交易了 1,188,750 股，较前一交易日的 377,256 股增加了 215%。该股票最后交易价格为 100.88 美元，之前收盘价为 99.29 美元。</p>
<h2>华尔街分析师观点</h2>
<p>一些股票分析师最近对 AMED 股票发布了报告。加拿大皇家银行在 4 月 16 日的研究报告中重申了对 Amedisys 的 “跑赢大盘” 评级，并设定了 100.00 美元的目标价。Wall Street Zen 在 5 月 24 日的研究报告中将 Amedisys 的评级从 “强力买入” 下调至 “买入”。</p>
<p><strong>查看我们最新的 Amedisys 股票报告</strong></p>
<h2>Amedisys 股票上涨 1.6%</h2>
<p>该公司的流动比率为 1.36，速动比率为 1.36，债务与股本比率为 0.26。该公司的 50 日简单移动平均线为 97.08 美元，200 日简单移动平均线为 94.31 美元。公司的市值为 33.2 亿美元，市盈率为 39.25，市盈增长比率为 1.34，贝塔值为 0.89。</p>
<p>Amedisys（纳斯达克代码：AMED - 获取免费报告）最后一次公布财报是在 7 月 29 日，健康服务提供商报告每股收益（EPS）为 1.54 美元，超出市场普遍预期的 1.39 美元，超出 0.15 美元。Amedisys 的净利润率为 3.56%，股本回报率为 12.91%。该公司本季度的收入为 6.2186 亿美元，而分析师预期为 6.1461 亿美元。去年同期，该公司的每股收益为 0.98 美元。本季度的收入较去年同期增长了 5.2%。整体来看，股票研究分析师预计 Amedisys, Inc.在本财年的每股收益将达到 4.4 美元。</p>
<h2>对 Amedisys 的对冲基金观点</h2>
<p>对冲基金和其他机构投资者最近增加或减少了对该公司的持股。Hexagon Capital Partners LLC 在第一季度将其在 Amedisys 的持股增加了 108.1%。Hexagon Capital Partners LLC 现在拥有 310 股该健康服务提供商的股票，价值 29,000 美元，此前在上一季度增持了 161 股。MassMutual Private Wealth &amp; Trust FSB 在第一季度将其在 Amedisys 的持股增加了 56.1%。MassMutual Private Wealth &amp; Trust FSB 现在拥有 334 股该健康服务提供商的股票，价值 31,000 美元，此前在上一季度增持了 120 股。Fifth Third Bancorp 在第一季度将其在 Amedisys 的持股增加了 68.1%。Fifth Third Bancorp 现在拥有 348 股该健康服务提供商的股票，价值 32,000 美元，此前在上一季度增持了 141 股。Caitong International Asset Management Co. Ltd 在第二季度购买了 Amedisys 的新头寸，价值约 32,000 美元。最后，UMB Bank n.a.在第一季度将其在 Amedisys 的持股增加了 100.0%。UMB Bank n.a.现在拥有 386 股该健康服务提供商的股票，价值 36,000 美元，此前在上一季度增持了 193 股。对冲基金和其他机构投资者持有该公司 94.36% 的股份。</p>
<h2>Amedisys 公司简介</h2>
<p>（获取免费报告）</p>
<p>Amedisys, Inc.及其子公司在美国提供医疗服务。它通过三个部门运营：家庭健康、临终关怀和高强度护理。家庭健康部门为患者从手术、慢性残疾或绝症的恢复提供一系列服务，并通过其专业护士预防可避免的住院再入；护理服务、专注于物理、语言和职业治疗的康复治疗师；以及社工和助理来协助患者。</p>
<h2>了解更多</h2>
<ul>
<li>我们更看好的五只股票比 Amedisys 更好</li>
<li>国会股票交易跟踪</li>
<li>微软股票上涨，分析师提高目标价</li>
<li>什么是股息冠军？如何投资于冠军</li>
<li>宇宙能源的盈利超出预期，标志着一个新时代</li>
<li>如何在 5 个简单步骤中做空股票</li>
<li>4 只半导体股票获得华尔街的新评级</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送电子邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Amedisys 吗？</h2>
<p>在你考虑 Amedisys 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前购买……而 Amedisys 并不在名单上。</p>
<p>虽然 Amedisys 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

阿米斯医疗

<p>Amedisys（纳斯达克代码：AMED）交易量显著增加，成交量达到 1,188,750 股，比前一交易日上涨 215%。股价从 99.29 美元上涨至 100.88 美元。分析师们的看法不一，加拿大皇家银行维持 “跑赢大盘” 评级，目标价为 100 美元，而华尔街 Zen 则将其评级下调至 “买入”。Amedisys 报告每股收益为 1.54 美元，超出预期，收入为 6.2186 亿美元，同比增长 5.2%。对冲基金持有该股票的 94.36%，显示出强烈的机构兴趣</p>

<p>Amedisys, Inc. (NASDAQ:AMED - Get Free Report) saw an uptick in trading volume on Thursday . 1,188,750 shares were traded during mid-day trading, an increase of 215% from the previous session's volume of 377,256 shares.The stock last traded at $100.88 and had previously closed at $99.29.</p>
<div class="lb-trans"><p>Amedisys, Inc.（纳斯达克代码：AMED - 获取免费报告）在周四的交易量有所上升。中午交易时段交易了 1,188,750 股，较前一交易日的 377,256 股增加了 215%。该股票最后交易价格为 100.88 美元，之前收盘价为 99.29 美元。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
</div><p>A number of equities analysts have recently issued reports on AMED shares. Royal Bank Of Canada reissued an &#34;outperform&#34; rating and set a $100.00 price target on shares of Amedisys in a research report on Wednesday, April 16th. Wall Street Zen downgraded shares of Amedisys from a &#34;strong-buy&#34; rating to a &#34;buy&#34; rating in a research note on Saturday, May 24th.</p>
<div class="lb-trans"><p>一些股票分析师最近对 AMED 股票发布了报告。加拿大皇家银行在 4 月 16 日的研究报告中重申了对 Amedisys 的 “跑赢大盘” 评级，并设定了 100.00 美元的目标价。Wall Street Zen 在 5 月 24 日的研究报告中将 Amedisys 的评级从 “强力买入” 下调至 “买入”。</p>
</div><p><strong>Check Out Our Latest Stock Report on Amedisys</strong></p>
<div class="lb-trans"><p><strong>查看我们最新的 Amedisys 股票报告</strong></p>
</div><h2>Amedisys Stock Up 1.6%</h2>
<div class="lb-trans"><h2>Amedisys 股票上涨 1.6%</h2>
</div><p>The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 0.26. The business's 50-day simple moving average is $97.08 and its 200-day simple moving average is $94.31. The company has a market capitalization of $3.32 billion, a PE ratio of 39.25, a price-to-earnings-growth ratio of 1.34 and a beta of 0.89.</p>
<div class="lb-trans"><p>该公司的流动比率为 1.36，速动比率为 1.36，债务与股本比率为 0.26。该公司的 50 日简单移动平均线为 97.08 美元，200 日简单移动平均线为 94.31 美元。公司的市值为 33.2 亿美元，市盈率为 39.25，市盈增长比率为 1.34，贝塔值为 0.89。</p>
</div><p>Amedisys (NASDAQ:AMED - Get Free Report) last announced its earnings results on Tuesday, July 29th. The health services provider reported $1.54 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.15. Amedisys had a net margin of 3.56% and a return on equity of 12.91%. The business had revenue of $621.86 million for the quarter, compared to analyst estimates of $614.61 million. During the same quarter last year, the business earned $0.98 earnings per share. The company's revenue for the quarter was up 5.2% compared to the same quarter last year. As a group, equities research analysts anticipate that Amedisys, Inc. will post 4.4 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Amedisys（纳斯达克代码：AMED - 获取免费报告）最后一次公布财报是在 7 月 29 日，健康服务提供商报告每股收益（EPS）为 1.54 美元，超出市场普遍预期的 1.39 美元，超出 0.15 美元。Amedisys 的净利润率为 3.56%，股本回报率为 12.91%。该公司本季度的收入为 6.2186 亿美元，而分析师预期为 6.1461 亿美元。去年同期，该公司的每股收益为 0.98 美元。本季度的收入较去年同期增长了 5.2%。整体来看，股票研究分析师预计 Amedisys, Inc.在本财年的每股收益将达到 4.4 美元。</p>
</div><h2>Hedge Funds Weigh In On Amedisys</h2>
<div class="lb-trans"><h2>对 Amedisys 的对冲基金观点</h2>
</div><p>Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Hexagon Capital Partners LLC lifted its stake in Amedisys by 108.1% in the first quarter. Hexagon Capital Partners LLC now owns 310 shares of the health services provider's stock worth $29,000 after acquiring an additional 161 shares during the last quarter. MassMutual Private Wealth &amp; Trust FSB boosted its holdings in Amedisys by 56.1% in the first quarter. MassMutual Private Wealth &amp; Trust FSB now owns 334 shares of the health services provider's stock valued at $31,000 after purchasing an additional 120 shares in the last quarter. Fifth Third Bancorp increased its stake in Amedisys by 68.1% in the first quarter. Fifth Third Bancorp now owns 348 shares of the health services provider's stock valued at $32,000 after purchasing an additional 141 shares during the last quarter. Caitong International Asset Management Co. Ltd purchased a new position in Amedisys in the second quarter valued at approximately $32,000. Finally, UMB Bank n.a. raised its holdings in Amedisys by 100.0% during the first quarter. UMB Bank n.a. now owns 386 shares of the health services provider's stock worth $36,000 after purchasing an additional 193 shares in the last quarter. Hedge funds and other institutional investors own 94.36% of the company's stock.</p>
<div class="lb-trans"><p>对冲基金和其他机构投资者最近增加或减少了对该公司的持股。Hexagon Capital Partners LLC 在第一季度将其在 Amedisys 的持股增加了 108.1%。Hexagon Capital Partners LLC 现在拥有 310 股该健康服务提供商的股票，价值 29,000 美元，此前在上一季度增持了 161 股。MassMutual Private Wealth &amp; Trust FSB 在第一季度将其在 Amedisys 的持股增加了 56.1%。MassMutual Private Wealth &amp; Trust FSB 现在拥有 334 股该健康服务提供商的股票，价值 31,000 美元，此前在上一季度增持了 120 股。Fifth Third Bancorp 在第一季度将其在 Amedisys 的持股增加了 68.1%。Fifth Third Bancorp 现在拥有 348 股该健康服务提供商的股票，价值 32,000 美元，此前在上一季度增持了 141 股。Caitong International Asset Management Co. Ltd 在第二季度购买了 Amedisys 的新头寸，价值约 32,000 美元。最后，UMB Bank n.a.在第一季度将其在 Amedisys 的持股增加了 100.0%。UMB Bank n.a.现在拥有 386 股该健康服务提供商的股票，价值 36,000 美元，此前在上一季度增持了 193 股。对冲基金和其他机构投资者持有该公司 94.36% 的股份。</p>
</div><h2>Amedisys Company Profile</h2>
<div class="lb-trans"><h2>Amedisys 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.</p>
<div class="lb-trans"><p>Amedisys, Inc.及其子公司在美国提供医疗服务。它通过三个部门运营：家庭健康、临终关怀和高强度护理。家庭健康部门为患者从手术、慢性残疾或绝症的恢复提供一系列服务，并通过其专业护士预防可避免的住院再入；护理服务、专注于物理、语言和职业治疗的康复治疗师；以及社工和助理来协助患者。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than Amedisys</li>
<li>Following Congress Stock Trades</li>
<li>Microsoft Stock Gains as Analysts Boost Price Targets</li>
<li>What Are Dividend Champions? How to Invest in the Champions</li>
<li>Constellation Energy’s Earnings Beat Signals a New Era</li>
<li>How to Short a Stock in 5 Easy Steps</li>
<li>4 Semiconductor Stocks Earning Fresh Wall Street Upgrades</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 Amedisys 更好</li>
<li>国会股票交易跟踪</li>
<li>微软股票上涨，分析师提高目标价</li>
<li>什么是股息冠军？如何投资于冠军</li>
<li>宇宙能源的盈利超出预期，标志着一个新时代</li>
<li>如何在 5 个简单步骤中做空股票</li>
<li>4 只半导体股票获得华尔街的新评级</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送电子邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Amedisys Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Amedisys 吗？</h2>
</div><p>Before you consider Amedisys, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Amedisys 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amedisys wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前购买……而 Amedisys 并不在名单上。</p>
</div><p>While Amedisys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Amedisys 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

阿米斯医疗（NASDAQ:AMED）出现异常高的交易量 - 原因如下